Ingrid Melle Selected Research

Psychotic Disorders (Schizoaffective Disorder)

1/2022	Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation.
1/2022	Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study.
1/2022	Premorbid characteristics of patients with DSM-IV psychotic disorders.
1/2022	Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis.
1/2022	The Time is Ripe for a Consensus Definition of Clinical Recovery in First-episode Psychosis: Suggestions Based on a 10-Year Follow-up Study.
1/2021	Sex-Specific Effect of Serum Lipids and Body Mass Index on Psychotic Symptoms, a Cross-Sectional Study of First-Episode Psychosis Patients.
1/2021	Childhood interpersonal trauma and premorbid social adjustment as predictors of symptom remission in first episode psychosis.
9/2020	Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study.
2/2020	Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients.
1/2020	Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingrid Melle Research Topics

Disease

74	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 05/2003
69	Schizophrenia (Dementia Praecox) 03/2022 - 09/2007
34	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 10/2009
24	Mental Disorders (Mental Disorder) 01/2022 - 11/2009
6	Substance-Related Disorders (Drug Abuse) 09/2020 - 09/2010
4	Wounds and Injuries (Trauma) 01/2021 - 10/2017
4	Cognitive Dysfunction 11/2019 - 01/2012
3	Brain Diseases (Brain Disorder) 10/2019 - 01/2009
3	Inflammation (Inflammations) 12/2016 - 09/2010
2	Neurodevelopmental Disorders 01/2022 - 09/2009
2	Dyslipidemias (Dyslipidemia) 01/2022 - 10/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2010
2	Vitamin D Deficiency 01/2018 - 07/2017
2	Vaccinia 01/2016 - 10/2011
2	Necrosis 02/2015 - 09/2010
2	Alcoholism (Alcohol Abuse) 02/2014 - 12/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Infections 01/2022
1	Genetic Risk Score 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Atherosclerosis 01/2020
1	Obesity 01/2019
1	Insulin Resistance 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Depressive Disorder (Melancholia) 01/2018
1	Weight Gain 01/2018

Drug/Important Bio-Agent (IBA)

35	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 01/2009
20	Antipsychotic Agents (Antipsychotics)IBA 03/2022 - 02/2009
8	Biological ProductsIBA 01/2022 - 01/2011
8	LipidsIBA 01/2022 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2009
7	C-Reactive ProteinIBA 01/2020 - 11/2009
7	Vitamin D FDA LinkGeneric 07/2018 - 12/2010
6	CholesterolIBA 01/2022 - 09/2010
6	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020 - 12/2010
5	Pharmaceutical PreparationsIBA 01/2021 - 12/2006
5	OsteoprotegerinIBA 10/2019 - 09/2010
5	Messenger RNA (mRNA)IBA 01/2019 - 12/2012
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 09/2012
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 10/2013
4	von Willebrand FactorIBA 05/2016 - 11/2009
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2016 - 11/2009
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2007
3	Cytokine Receptor gp130IBA 01/2022 - 01/2020
3	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2022
3	HDL CholesterolIBA 01/2021 - 09/2012
3	Oxytocin (Pitocin)FDA LinkGeneric 11/2016 - 01/2014
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2016 - 11/2009
3	Antidepressive Agents (Antidepressants)IBA 02/2016 - 06/2011
3	Genetic Markers (Genetic Marker)IBA 01/2016 - 01/2012
3	Interleukin-6 (Interleukin 6)IBA 02/2015 - 11/2009
3	Glucose (Dextrose)FDA LinkGeneric 09/2012 - 05/2008
3	EnzymesIBA 12/2010 - 03/2010
2	InflammasomesIBA 01/2022 - 01/2022
2	LigandsIBA 01/2022 - 11/2009
2	oxidized low density lipoproteinIBA 01/2021 - 10/2019
2	Tryptophan (L-Tryptophan)FDA Link 01/2020 - 03/2010
2	Olanzapine (Zyprexa)FDA Link 12/2018 - 01/2017
2	LithiumIBA 12/2016 - 08/2015
2	Oxytocin Receptors (Oxytocin Receptor)IBA 11/2016 - 01/2015
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2016 - 07/2015
2	Phosphotransferases (Kinase)IBA 01/2016 - 10/2011
2	CD40 Ligand (CD40L)IBA 02/2015 - 11/2009
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 05/2012 - 01/2012
2	Transcription Factor 4IBA 10/2011 - 08/2009
2	NeurograninIBA 10/2011 - 08/2009
2	Nerve Growth Factors (Neurotrophins)IBA 02/2011 - 06/2009
2	DysbindinIBA 01/2009 - 01/2009
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2009 - 01/2009
1	Hormones (Hormone)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	OF 743IBA 01/2022
1	CytokinesIBA 01/2022
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2022
1	B-Cell Activating FactorIBA 01/2022
1	Nootropic Agents (Nootropics)IBA 01/2021
1	serum P-component (CIt)IBA 01/2021
1	FurinIBA 01/2021
1	BuffersIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	purineIBA 01/2020
1	HDL-triglycerideIBA 01/2020
1	HDL LipoproteinsIBA 01/2020
1	LDL CholesterolIBA 01/2020
1	KynurenineIBA 01/2020
1	LeptinIBA 01/2019
1	AdiponectinIBA 01/2019
1	AdipokinesIBA 01/2019
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2018
1	Blood Proteins (Serum Proteins)IBA 01/2018

Therapy/Procedure

10	Transjugular Intrahepatic Portasystemic Shunt 01/2019 - 08/2005
2	Treatment Delay 10/2013 - 09/2010
1	Patient Care 01/2022
1	Polypharmacy 01/2018